Johnson & Johnson advances the next generation of solid tumor therapies with new data at ESMO 2026
October 23, 2026
October 23, 2026
NEW BRUNSWICK, New Jersey, Oct. 23 [Category: BizHealth & Beauty] -- Johnson and Johnson posted the following news release:
* * *
Johnson & Johnson advances the next generation of solid tumor therapies with new data at ESMO 2026
*
New Brunswick, N.J., October 23, 2026 - Johnson & Johnson (NYSE:JNJ) will present more than 25 abstracts from its solid tumor portfolio and pipeline at the 2026 European Society for Medical Oncology (ESMO) . . .
* * *
Johnson & Johnson advances the next generation of solid tumor therapies with new data at ESMO 2026
*
New Brunswick, N.J., October 23, 2026 - Johnson & Johnson (NYSE:JNJ) will present more than 25 abstracts from its solid tumor portfolio and pipeline at the 2026 European Society for Medical Oncology (ESMO) . . .